Mode
Text Size
Log in / Sign up

CHGZGJT combined with conventional treatment improves HbA1c, fasting glucose, and lipid profiles in Type 2 DiabetesHerbal Formula May Improve Blood Sugar in Type 2 Diabetes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that CHGZGJT combined with conventional treatment may improve glycemic control and lipid profiles in T2DM patients.

This systematic review and meta-analysis evaluated the efficacy of CHGZGJT combined with conventional treatment in patients with Type 2 Diabetes Mellitus (T2DM). The analysis included data from 883 patients to assess primary outcomes including HbA1c, fasting plasma glucose (FPG), and 2h postprandial glucose (2hPG).

The meta-analysis reported significant improvements in glycemic control: HbA1c decreased by 0.69%, FPG decreased by 0.86 mmol/L, and 2hPG decreased by 0.74 mmol/L. Secondary outcomes showed a decrease in fasting insulin (FINS) by 2.08 µIU/mL and HOMA-IR by 0.79, while HOMA-β increased by 5.13. Additionally, the lipid profile including total cholesterol, triglyceride, and LDL-C was lowered.

The authors noted that the quality of evidence from included studies was low to moderate. While the intervention showed a favorable safety profile for short-term administration with a lower risk of adverse events (RR = 0.44), high-quality clinical trials are still warranted to verify long-term efficacy and safety. Clinical application should be approached with caution due to these evidence limitations.

How this fits prior evidence

This finding addresses a gap in non-pharmacological or adjunctive herbal interventions for T2DM management. While prior coverage noted that combined exercise interventions significantly reduce glycated hemoglobin and fasting blood glucose, and incretin-based therapies provide superior glycemic control compared to placebo, this meta-analysis provides specific evidence on the efficacy of CHGZGJT as an adjunct to conventional treatment for improving both glycemic markers and lipid profiles.

Researchers analyzed data from 883 patients with type 2 diabetes to see if a traditional herbal formula, known as Chaihu Guizhi Ganjiang Tang (CHGZGJT), could improve health outcomes when added to standard treatments. The study looked at several markers of blood sugar control and heart health.

The results showed that patients who took the herbal mixture saw a decrease in HbA1c levels, fasting plasma glucose, and 2-hour postprandial glucose. The formula also appeared to improve insulin resistance and beta-cell function while lowering total cholesterol, triglycerides, and LDL cholesterol. These findings suggest the herb may offer additional benefits for managing diabetes symptoms.

However, it is important to note that the quality of the evidence from these studies was only low to moderate. Because the data comes from a meta-analysis of existing trials rather than one large new study, more high-quality clinical trials are needed to confirm how well this works over a long period. You should talk with your doctor before adding any new supplements or herbal treatments to your current medical plan.

What this means for you:
This herbal formula may help manage blood sugar and cholesterol in type 2 diabetes, but more high-quality research is needed.

Common questions

What did the study find about blood sugar?

The analysis of 883 patients showed that adding the herbal formula to standard treatment led to lower HbA1c, fasting plasma glucose, and 2-hour postprandial glucose. These results suggest it may help improve overall glycemic control for those with type 2 diabetes.

Does this herb affect cholesterol levels?

Yes, the study reported that the herbal formula was associated with a lower lipid profile. Specifically, it helped decrease total cholesterol, triglycerides, and low-density lipoprotein (LDL) cholesterol in patients with type 2 diabetes.

Is this treatment safe for people with diabetes?

The study reported a favorable safety profile for short-term use and found a lower risk of adverse events. However, because the evidence quality is only low to moderate, you should consult your doctor before starting any new herbal supplement.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundThe pathological mechanisms of type 2 diabetes mellitus (T2DM) are complex and necessitate multi-target intervention strategies. Chaihu Guizhi Ganjiang Tang (CHGZGJT), a classical formula derived from the ancient canonical text Shanghan Lun (Treatise on Cold Damage Diseases), has been reported to improve glucose and lipid metabolism as well as islet function in patients with T2DM. However, a quantitative evidence-based evaluation is currently lacking. This study aimed to systematically evaluate the overall efficacy and safety of CHGZGJT.MethodsThis study was registered on the PROSPERO platform. Eight Chinese and English databases and two clinical trial registries were systematically searched, and 12 clinical controlled trials involving a total of 883 patients were ultimately included. Meta-analysis were performed using R software to assess efficacy and safety.ResultsThe meta-analysis suggested that CHGZGJT combined with conventional treatment significantly reduced glycated hemoglobin (HbA1c, MD = −0.69%), fasting plasma glucose (FPG, MD = −0.86 mmol/L), and 2-h postprandial glucose (2hPG, MD = −0.74 mmol/L) in patients with T2DM. At the mechanistic level, this regimen significantly decreased fasting insulin (FINS, MD = −2.08 µIU/mL) and the homeostasis model assessment of insulin resistance (HOMA-IR, MD = −0.79), improved islet β-cell function (HOMA-β, MD = 5.13), and lowered total cholesterol, triglyceride, and low-density lipoprotein cholesterol levels, with a lower risk of adverse events (RR = 0.44).ConclusionCHGZGJT may improve glycemic control, insulin resistance, β-cell function, and the lipid profile in patients with T2DM, with a favorable safety profile for short-term administration. However, the quality of evidence from the included studies was low to moderate, and high-quality clinical trials are still warranted to further verify its long-term efficacy and safety.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.